About the webinar
Have you ever asked yourself:
- What is indicated?
- What is likely to help?
- What may help some?
- What harms?
In this second of two webinars, Dr Mark Donohoe outlines a practical management approach for common symptoms and co-morbidities that present in ME/CFS and long COVID. “There are no magic bullets”. But developing treatment and management strategies for identified symptoms and co-morbidities can go a long way to improving your patient’s quality of life
Learning outcomes
Evaluate evidence from the patient, literature and clinical experience to develop management plans for ME/CFS or long COVID, including treating common symptoms and co-morbidities
Target audience and accreditation
This introductory webinar was developed for General Practitioners and will benefit those who have no to little knowledge on the topic. It will also serve as a refresher to those who already have some knowledge. Other practice staff and health professionals will also benefit.
RACGP activity ID – 1038155
All participants will be automatically issued a certificate on completion of the webinar for your records.
Your speaker
Dr Mark Donohoe, GP President ACNEM, Founder, Director, Mosman Integrative Medicine
Dr Mark has worked in the field of ME/CFS for over 35 years, and is considered one of Australia’s leading practitioners in this area. He is currently President of the Australasian College of Nutritional & Environmental Medicine (ACNEM)
Dr Mark sees patients from around Australia and overseas with complex illnesses, including chronic fatigue syndrome (CFS), myalgic encephalomyelitis (ME), fibromyalgia (FM), chemical toxicity and sensitivities (MCS) and chronic inflammation.
Treatment usually starts with non-drug therapies, including diet, exercise and lifestyle change, moving on to specific, individualised therapeutic needs of each patient. His preference is for employing very specific non drug therapies to restore capacity and balance, and to achieve long-term, sustainable recovery.
